DHB is short for dihydroboldenone, a synthetic anabolic steroid also known as 1-testosterone. It is not a pharmaceutical drug and was never approved for medical use. Instead, it emerged as a designer steroid used in bodybuilding and performance enhancement circles for its reputation of promoting lean muscle growth with relatively lower estrogenic activity compared to testosterone.
How DHB Differs From Testosterone
Dihydroboldenone’s chemical name is 17β-hydroxy-5α-androst-1-en-3-one. Structurally, it is very close to testosterone, with one key difference: the double bond in its ring structure sits in a different position (between carbons 1 and 2 instead of carbons 4 and 5). That small shift changes how the molecule behaves in the body. DHB displays high anabolic effects, meaning it is potent at stimulating muscle protein synthesis, while its androgenic effects (the traits linked to masculinization, like body hair growth and deepening voice) are considered moderate by comparison.
Despite the name “dihydroboldenone,” DHB is not simply a reduced form of boldenone (the steroid found in Equipoise). The naming convention is based on its chemical structure, which can be misleading. In practice, users describe DHB’s effects as closer to a cross between testosterone and a milder compound, producing harder, leaner gains without as much water retention.
What Users Take It For
The primary reason people use DHB is to increase muscle size and strength. Anabolic steroids in general work by binding to androgen receptors inside cells. Once bound, the receptor moves into the cell’s nucleus, where it acts as a switch that turns on genes responsible for muscle protein production. The result, when combined with resistance training, is both larger individual muscle fibers and the creation of entirely new muscle fibers. Research on strength-trained athletes using anabolic steroids has shown significantly larger muscle fiber cross-sectional area compared to non-users, along with a higher number of nuclei within each fiber, a sign of enhanced growth capacity.
DHB is often favored during “cutting” phases or lean-bulking cycles because users report less bloating and water retention than with testosterone or other wet compounds. It does not convert to estrogen at a meaningful rate, which is a major part of its appeal. High estrogen levels from other steroids can cause fluid retention, fat gain around the chest, and gynecomastia (breast tissue growth in men). DHB largely sidesteps those issues.
Typical Dosing Patterns
DHB is most commonly available as dihydroboldenone cypionate, an injectable form. Underground sources typically recommend the following weekly dosages:
- Beginner: 250 to 500 mg per week
- Intermediate: 500 to 750 mg per week
- Advanced: 750 to 1,000 mg per week
Cycle lengths generally run 12 to 16 weeks. Because DHB was never developed as a pharmaceutical product, none of these dosages come from clinical research. They are based entirely on anecdotal use within the bodybuilding community, meaning there is no established safety profile for any dose.
One frequently mentioned drawback of DHB injections is post-injection pain (PIP). Many users report that DHB causes significant soreness, swelling, and inflammation at the injection site, sometimes lasting several days. This is one of the most common complaints and a reason some people avoid the compound despite its other characteristics.
Side Effects and Health Risks
Because DHB has moderate androgenic activity, it carries androgenic side effects. These include acne, oily skin, and accelerated hair loss in people genetically prone to male pattern baldness. Increased activity of androgens at hair follicles can shrink the follicles and shorten the hair growth cycle, gradually thinning hair on the top and front of the scalp. Prostate enlargement is another concern with prolonged androgen exposure, which can cause difficulty urinating and sexual dysfunction.
Like all anabolic steroids, DHB suppresses your body’s natural testosterone production. During a cycle, the hypothalamic-pituitary-gonadal axis detects elevated androgen levels and reduces its own signaling, effectively shutting down testicular testosterone output. After stopping, recovery can take weeks to months, and some users experience low energy, mood changes, loss of libido, and muscle loss during this period. Most users plan a post-cycle therapy protocol to try to accelerate recovery, though this carries its own risks.
Cardiovascular effects are also a concern. Anabolic steroids tend to shift cholesterol levels in an unfavorable direction, lowering HDL (the protective type) and raising LDL. Over time, this increases the risk of arterial plaque buildup and cardiovascular disease. Liver stress is generally lower with injectable steroids than oral ones, but it is not zero, particularly at higher doses or longer cycle lengths.
Legal Status
In the United States, DHB is explicitly listed as a Schedule III controlled substance under federal law. The Code of Federal Regulations (21 CFR § 1308.13) names Δ1-dihydrotestosterone, also known as 1-testosterone, among the specific anabolic steroids included in Schedule III. Possessing, distributing, or manufacturing it without a valid prescription is a federal offense. Since DHB has no approved medical use, legitimate prescriptions do not exist for it.
Most other countries with anabolic steroid regulations classify it similarly. In the UK, anabolic steroids are Class C drugs under the Misuse of Drugs Act. In Canada and Australia, they are controlled substances as well. Purchasing DHB typically means sourcing it from underground laboratories, which introduces additional risks: inconsistent dosing, contamination, and no quality control.
How It Compares to Other Steroids
DHB occupies a middle ground in the steroid landscape. It is stronger than compounds like Primobolan but generally considered milder than trenbolone. Its low estrogenic conversion makes it appealing to users who want to avoid anti-estrogen medications during a cycle. Its moderate androgenic rating means side effects like hair loss and acne are present but typically less aggressive than with highly androgenic compounds like trenbolone or Anadrol.
The tradeoff is that DHB is harder to source than mainstream compounds, often more expensive, and the injection pain can be severe enough to limit how frequently and comfortably users can administer it. For these practical reasons, it remains a niche choice rather than a staple in most steroid cycles.